Kenneth J. Linton

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

A genes and health recall study of intrahepatic cholestasis of pregnancy and cholestatic liver disease.

A genes and health recall study of intrahepatic cholestasis of pregnancy and cholestatic liver disease.

Journal: Communications medicine

Published: October 11, 2024

Molecular Modeling Studies to Probe the Binding Hypothesis of Novel Lead Compounds against Multidrug Resistance Protein ABCB1.

Molecular Modeling Studies to Probe the Binding Hypothesis of Novel Lead Compounds against Multidrug Resistance Protein ABCB1.

Journal: Biomolecules

Published: November 27, 2023

Structural basis for the modulation of MRP2 activity by phosphorylation and drugs.

Structural basis for the modulation of MRP2 activity by phosphorylation and drugs.

Journal: Nature communications

Published: October 05, 2023

Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1).

Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1).

Journal: International journal of molecular sciences

Published: December 19, 2022

Rare variant contribution to cholestatic liver disease in a South Asian population in the United Kingdom.

Rare variant contribution to cholestatic liver disease in a South Asian population in the United Kingdom.

Journal: Scientific reports

Published: December 14, 2022

ABCB1 Does Not Require the Side-Chain Hydrogen-Bond Donors Gln347, Gln725, Gln990 to Confer Cellular Resistance to the Anticancer Drug Taxol.

ABCB1 Does Not Require the Side-Chain Hydrogen-Bond Donors Gln347, Gln725, Gln990 to Confer Cellular Resistance to the Anticancer Drug Taxol.

Journal: International journal of molecular sciences

Published: May 28, 2021

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy.

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy.

Journal: Cancers

Published: May 06, 2020

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 30, 2019

ABCC3 is a novel target for the treatment of pancreatic cancer.

ABCC3 is a novel target for the treatment of pancreatic cancer.

Journal: Advances in biological regulation

Published: April 12, 2019

Contribution of rare coding mutations in CD36 to type 2 diabetes and cardio-metabolic complications.

Contribution of rare coding mutations in CD36 to type 2 diabetes and cardio-metabolic complications.

Journal: Scientific reports

Published: January 14, 2019

Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex.

Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex.

Journal: Cellular and molecular life sciences : CMLS

Published: March 13, 2018

A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.

A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.

Journal: Cancer research

Published: September 20, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026